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INTRODUCTION 
 Diarrhoea in enterally tube fed (ETF) critically ill patients is a frequently 
experienced and multi factorial problem (Thorson et al, 2008). Although rarely 
associated with mortality, diarrhoea is distressing to patients, visitors and staff (Martin, 
2007). 
 
Enteral tube feeding is often debated as a main cause of diarrhoea (Lee and 
Auyeung, 2003; Ukleja, 2010). Approximately 46% to 77% of all critically ill patients 
will receive enteral nutrition (EN) during their intensive care unit (ICU) admission 
(McKenna et al, 2001; Lee and Auyeung, 2003; Gramlich et al, 2004; Whelan, et al., 
2006; Whelan et al, 2007). The early commencement of EN is suggested to preserve the 
gut’s immunological barrier, reduce bacterial translocation, reduce sepsis and multi 
organ failure and improve wound healing (Davies and Bellomo, 2004; Marshall and 
West, 2004; Artinian et al, 2006; Nguyen, et al., 2007; Lopez-Herce, et al., 2008; 
Lopez-Herce, 2009; McClave and Heyland, 2009; Ukleja, 2010). 
 
Incidence of diarrhoea 
The reported incidence of ETF diarrhoea is suggested to vary between 2% to 
68% (Bengmark, 2002; McNaught, et al., 2005; Weisen, et al., 2006; Luft et al, 2008; 
Whelan et al, 2009). However, diarrhoea in ETF critically ill patients is more diverse 
with the reported incidence varying between 2% to 95% of all patients (Whelan et al, 
2009). The variability of diarrhoea incidence depends on the diagnostic criteria and 
definitions used to identify and quantify diarrhoea (Lopez-Herce, 2009). 
 
Causes of diarrhoea in the ETF patient 
 The causes of ETF related diarrhoea include physiological responses to critical 
illness, altered colonic responses to intragastric feeding, microbial contamination of the 
ETF formulae, sterile ETF formulae, constant flow administration of ETF formulas, low 
fibre ETF formulas, hypoalbuminaemia, disturbances to intestinal flora, increased 
exposure to antibiotics, and concurrent pharmacotherapy such as aperients, prokinetics 
and histamine-2 medications (Weisen et al, 2006; Ferrier and East, 2007; Sabol and 
Carlson, 2007; Whelan et al, 2007; Lopez-Herce, 2009; Btaiche et al, 2010). In addition, 
the diagnosis, severity of illness and co morbidities of patients can contribute to 
diarrhoea in critically ill patients (Thorson et al, 2008). 
 
Diarrhoea management strategies 
 Inconsistent diarrhoea management practices are evident between different 
ICU’s (Dorman et al, 2004; Ferrie and East, 2007). Strategies to manage ETF related 
diarrhoea include diarrhoea management algorithms, anti-diarrhoeal medications, 
electrolyte and fluid replacement, continuation of ETF, administering probiotics, 
prebiotics and synbiotics, and the administration of glycopeptides and metronidazole for 
infectious diarrhoea (Whelan et al, 2006; Lopez-Herce, 2009). It could be argued that 
the variations in bowel care management strategies in ICU lead to diarrhoea in critically 
ill patients. 
 
 It was noted that the reported incidence of ETF related diarrhoea in critically ill 
patients is well established in regards to interventional research such as administration 
of fibre containing ETF formulas and probiotics (Bleichner, et al, 1997; DeMao, et al., 
1998; Lee and Auyeung, 2003; Whelan, et al., 2006; Lopez-Herce, 2009). However, 
there remains a paucity of literature addressing the incidence and frequency of diarrhoea 
in ETF critically ill patients in relation to ETF formulae, diarrhoea incidence and 
duration, hypoalbuminaemia, infection, antibiotic therapy and concomitant 
pharmacotherapy within in a single centre tertiary referral ICU. 
 
METHODS 
A five month, retrospective, repeated measures cohort study was undertaken.  
 
Study Aims and Research Questions 
The aim of this study was to examine the causes of ETF diarrhoea in a single centre 
ICU. The research questions that guided this study include: 
1. What is the incidence of ETF diarrhoea in the ICU? 
2. Is the duration and incidence of diarrhoea related to the type of ETF 
administered? 
3. Is the duration and incidence of diarrhoea related to the duration of ETF? 
4. Do patients develop diarrhoea when the commencement of ETF is delayed? 
5. Is diarrhoea incidence and duration influenced by age, gender and Acute 
Physiology and Chronic Health Evaluation (APACHE II) scores? 
6. Does the duration of antibiotic therapy, aperients/prokinetic/sedation/paralysis 
administration affect the incidence and duration of diarrhoea? 
7. Is diarrhoea related to hypoxia, hypoalbuminaemia, hypoglycaemia and elevated 
white blood cell counts? 
 
Setting 
The research setting was a twenty-two bed, single site, Level III ICU of a major 
teaching and tertiary referral, metropolitan hospital in Brisbane, Australia. A Level III 
Australian ICU is a tertiary referral unit that provides comprehensive critical care 
services for critically ill patients who require multi-system life support for indefinite 
periods of time. These ICUs also demonstrate a commitment to academic education and 
research (Joint Faculty of Intensive Care Medicine (JFICM), 2003). 
 
Ethical Approval 
Ethical approval was obtained from the local hospital and university human 
research ethics committees. 
 
Participants 
Participants were recruited using non-probability, retrospective sequential 
sampling of all emergency admission ICU patients who met the inclusion/exclusion 
criteria. Patients were eligible for inclusion if they: 1) were enterally tube fed via 
continuous infusion; 2) ≥18 years of age; and 3) were expected to have an ICU length of 
stay (LOS) >5 days. Participants were excluded from the study if they were: 1) 
immunocompromised; 2) suffered burns/hepatic failure; and 3) elective post operative 
patients. Consent was not obtained from participants as this study fulfilled the criteria of 
a quality assurance activity. Study participants were de-identified to a study number. A 
password protected enrolment log was maintained of study participants. 
 
Data Collection 
Data were collected retrospectively by review of medical records. A data 
collection tool was developed for this study (see Table 1). Data were collected to a 
maximum of fourteen days into the patients ICU admission or until the patient’s 
discharge from ICU, whichever occurred first. It was deemed necessary to collect data 
for this length of time as diarrhoea is often not observed in the initial five to seven days 
of a patient’s ICU admission. For this study, diarrhoea was defined as the ‘abnormal 
passage of loose or liquid stools more than three times daily and/or a volume of stool 
greater than 200g/day during the patient’s ICU admission’ (Thomas et al, 2003). 
 
No validated diarrhoea measurement tool was used in the ICU at the time of this 
study. Faecal output was recorded subjectively by nursing staff using the CareVue 
computer information management system. Faecal volume was recorded by nurses as 
small (<100ml), medium (100-200ml) and large (<200ml). Stool consistency was 
recorded as formed, semi-formed, loose, or watery. Data for this study was collected 
retrospectively at one point in time; therefore, education of nurses regarding the use of a 
faecal output measurement tool was not appropriate. The consistency of nursing 
documentation was unable to be checked due to the retrospective methodological design 
of this study. Faecal volume and consistency were then cross referenced by the 
researcher using the Bristol Stool Chart, which is a validated diarrhoea identification 
tool (Dorman et al, 2004). 
 
Operational definitions used to guide this research include: 
1. Diarrhoea: diarrhoea was either experience of not experience by the patient; 
2. Diarrhoea episode: one event of diarrhoea experienced by a patient; 
3. Diarrhoea duration: the number of days a patient experienced diarrhoea during 
their ICU admission; 
4. Diarrhoea frequency: the total diarrhoea episodes experienced by a patient 
during their ICU admission; 
5. Total diarrhoea days: the total number of days a patient experienced diarrhoea 
during their ICU admission. 
 
Data Analysis 
Data analyses were performed using the Statistical Package for the Social 
Sciences (SPSS) version 16. Descriptive statistics of patient demographics were 
performed using means and standard deviations (SD). Normality was assessed using 
Kolmogorov-Smirnov test. Univariate and bivariate correlations were assessed using the 
Pearson or Spearman Rho coefficient. Univariate associations were analysed using Chi 
square statistical test. A general linear model was used to explore univariate 
relationships. The Kruskal-Wallis test was performed to explore the variance between 
skewed continuous variables across groups. The Mann-Whitney U Test was used to 
explore non-parametric means. Generalised estimated equations (GEE) modelling was 
used to analyse the within subject variation across the repeated measures analysis. For 
all analyses, a p <0.05 was considered statistically significant. 
 
RESULTS 
Fifty patients were retrospectively audited over five months (January to May 
2007). Patient demographic data are outlined in Table 2. The majority of patients (n = 
39; 78%) developed diarrhoea. Diarrhoea was observed on 121 days (19%) of the 644 
patient admission days. Single episodes of diarrhoea were observed 326 times (SD 7.3) 
over 449 ETF days (SD 3.3). Patients experienced 0 to 8 episodes of diarrhoea daily. 
However, the total single episodes of diarrhoea per patient admission varied between 0 
to 29 episodes. Antibiotics, aperients, prokinetics and sedation were administered to 
most patients (Figure 1). Individual intestinal pro-motility and sedation medications 
administered to patients in this study are outlined in Figures 2 and 3. 
 
No statistically significant difference between the patients’ age and diarrhoea 
frequency (r = 0.003; p = 0.982) and diarrhoea duration (r = 0.122; p = 0.397) was 
observed. Gender did not influence diarrhoea (2 = -0.188; p = 0.191), diarrhoea 
frequency (r = -0.207; p = 0.149) or diarrhoea duration (r = -0.183; p = 0.204) (Table 3). 
Higher APACHE II scores were associated with a higher frequency of diarrhoea (r = 
0.334; p = 0.018) and a longer duration of diarrhoea (r = 0.372; p = 0.008). Patients who 
had a longer ICU LOS were more likely to develop diarrhoea (2 = 0.535; p <0.01) and 
experience a longer duration of diarrhoea (2 = 0.915; p < 0.001); however, statistical 
significance was not found between the ICU LOS and diarrhoea frequency (Table 3). 
 
Enteral Nutrition and incidence of diarrhoea 
All patients received ETF at some point during their ICU admission. Enteral 
tube feeding formulas consisted of Jevity Plus (n = 37; 74%), Jevity (n = 6; 12%), 
Nepro (n = 7; 14%) or another formulae (n = 0) at the start of ETF. Nine patients (18%) 
had their ETF formula changed (Jevity Plus n = 1; Jevity n = 1; Nepro n = 5; Other n = 
1) during their ICU admission. The ETF formula was not associated with the 
development of diarrhoea (2 = 2.540; p = 0.281). Additionally, no relationship was 
observed between diarrhoea and the changing of the ETF formula (2 = 3.096; p = 
0.542). The duration (2 = 3.469; p = 0.177) and frequency (2 = 3.633; p = 0.163) of 
diarrhoea was not associated with the EFT formulae. 
 
Total diarrhoea days (r = 0.422; p = 0.02) and diarrhoea frequency (r = 0.313; p 
= 0.027) increased when the patient was ETF for longer periods of time. Significant 
relationships were not found between diarrhoea (r = -0.152; p = 0.291), total diarrhoea 
days (r = 0.032; p = 0.825), diarrhoea frequency (r = -0.067; p = 0.646) and time delay 
from ICU admission to the commencement of ETF. Controlling for total ETF days did 
not demonstrate a relationship between the development of diarrhoea (r = -0.036; p = 
0.806), total diarrhoea days (r = 0.240; p = 0.096) or diarrhoea frequency (r = 0.191; p = 
0.189) with respect to the time delay from ICU admission to the start of ETF. Of 
particular interest though was that the duration of diarrhoea was linearly associated with 
the frequency of diarrhoea (2 = 0.915; p < 0.001). 
 
Medications administered 
An increased duration of diarrhoea was associated with total antibiotic days (r = 
0.300; p = 0.034) and sedation days (r = 0.363; p = 0.010). Patients who developed an 
infection (Md = 3; n = 33) compared to those patients who did not develop an infection 
(Md = 2; n = 17) were more likely to experience an increased duration of diarrhoea (U = 
175; z = -2.200; p = 0.028; r = 0.31). The duration of diarrhoea was not associated with 
the duration of aperients (r = -0.033; p = 0.818), prokinetics (r = 0.135; p = 0.349) and 
neuromuscular blockade medications (r = 0.158; p = 0.274) days. 
 
 Similarly, an increase in diarrhoea frequency was associated with total antibiotic 
days (r = 0.320; p = 0.023) and total sedation (r = 0.362; p = 0.010) days. Patients who 
developed an infection (Md = 7; n = 33) experienced an increased frequency of 
diarrhoea compared to those patients who did not experience an infection (Md = 1; n = 
17) (U = 162; z = -2.444; p = 0.015; r = 0.35). The frequency of diarrhoea demonstrated 
no relationship with the duration of aperients (r = -0.099; p = 0.493), prokinetics (r = 
0.101; p = 0.486), and neuromuscular blockade medications (r = 0.203; p = 0.157) days. 
 
Physiological variables 
 This study applied GEE modelling for repeated measures of physiological data 
to describe the within subject variability that could not be explained using a repeated 
measures ANOVA test. Table 4 demonstrates that all binary and covariate physiological 
variables used in this study are significant. Positive associations were found between the 
dependent variable of diarrhoea and all explanatory variables of total ETF days, 
glucose, albumin, white cell counts. 
 
Infectious diarrhoea (Aeromonas hydrophilia spp) was observed in the first of 
two stool cultures in one patient. The stool cultures were collected on days four and 
seven of the patient’s ICU admission. Aeromonas spp infections have previously been 
associated with gastroenteritis in children; however, the role of this bacteria in relation 
to infection remains unclear and caution related to the cause of diarrhoea in this patient 
was applied (Forbes, Sahm & Weissfeld; 2007). No other infectious causes of diarrhoea 
such as Clostridium difficile, Salmonella or Shigella were cultured. 
 
DISCUSSION 
The key result of this retrospective clinical chart audit is that the high frequency 
of diarrhoea in ETF critically ill patients (n=39; 78%) is not attributed to one causal 
factor. Rather, many factors influence the frequency and duration of diarrhoea in 
critically ill patients. This high frequency of diarrhoea supports the findings of similar 
studies and suggests that diarrhoea is common in the ICU environment (Bengmark, 
2002; Lebak, 2003; Ferrie and East 2007). 
 
 No general consensus of diarrhoea definition is used in the clinical setting 
(Lebak et al, 2003; Whelan et al, 2003; Martin, 2007; Sabol and Carlson, 2007). 
Although a stringent definition of diarrhoea was used by this study, a similar definition 
was not used by clinicians in the ICU where the study was undertaken. Diarrhoea 
definitions that rely on clinical judgement in the absence of standardised criteria are 
fraught with complications (Lebak et al, 2003) and should be avoided. In the absence of 
a standardised diarrhoea definition, a taxonomy of definitions embracing stool 
frequency, consistency, duration and weight is suggested (Lebak et al, 2003). Diarrhoea 
prevalence is lower when stringent, measurable diarrhoea definitions are used (Lee and 
Auyeung, 2003; Whelan et al, 2003; Whelan et al, 2008). The higher prevalence of 
diarrhoea may have been influenced by the definition and diagnostic qualities of 
diarrhoea used in this study. 
 
Enteral nutrition has been previously associated as a risk factor for diarrhoea 
(Thorson et al, 2008; Whelan et al, 2009). Some risk factors related to enteral nutrition 
were controlled for in this study. The ETF formula was delivered via a closed sterile 
system. The ETF formula and administration flow sets were changed every 24 hours. 
All patients were fed via continuous infusion. Diarrhoea related to bolus feeding was 
therefore minimised. There was no report of infectious diarrhoea in this study. 
 
 In this study, the type or osmolality of the ETF formula was not found to affect 
the frequency or duration of diarrhoea. These findings are supported by seminal 
research conducted by Pesola et al (1990) who demonstrated that the osmolality of ETF 
formulas did not increase in the incidence of diarrhoea is healthy volunteers (n = 5) and 
ward (n = 10) and ICU patients (n = 24). Diarrhoea developed in only three ICU 
patients in Pesola’s study (1990); however, these patients had an average albumin level 
of 2.8 g/dl. This diarrhoea finding was not statistically significant (Pesola et al, 1990). 
Similar to Pesola’s study (1990), an average hypoalbuminaemia of <30g/L was reported 
in 34% (n=17) of patients in the clinical chart audit undertaken for this study. Statistical 
significance was also not observed in the clinical chart audit. 
 
 Several other diarrhoea risk factors have been identified in other studies and 
include APACHE II scores, longer ICU LOS, infection, bolus ETF, previous total 
parenteral nutrition (TPN), hypoalbuminaemia, fever or hypothermia (Heyland, 2000; 
Barbut and Meynard, 2002; Marshall and West, 2004; Thorson et al, 2008; Lopez-
Herce, 2009). In this study, the presence of numerous risk factors including time delay 
to initial bowel activity, total ETF days, total antibiotic days, total prokinetic days, and 
ICU LOS influenced the frequency and duration of diarrhoea in critically ill patients. 
 
 Infection has been previously identified as a risk factor for diarrhoea in ETF 
critically ill patients. This study re-affirmed the significant relationships between 
infection and diarrhoea incidence and duration. However, caution must be exercised in 
regards to these relationships as the presence of infection in critical illness may also be 
influenced by higher severity of illness scores, antibiotic use and increased ICU LOS. 
 
 High severity of illness scores including APACHE II scores was associated with 
an increased frequency and duration of diarrhoea. Critically ill patients who are more 
acutely ill may experience a hyper metabolic stress response, altered gut 
pathophysiology such as increased intestinal lumen permeability, electrolyte 
imbalances, and altered immune responses (Ferrie and East, 2007; Thorson et al, 2008). 
 
 The significant relationships found between diarrhoea, duration of ETF, glucose 
control, albumin and white cell counts have been inconsistently reported elsewhere. 
These findings require further examination in studies with larger sample sizes. 
 
STRENGTHS AND LIMITATIONS 
This study was a retrospective, single centre cohort clinical chart audit and as 
such the findings may not be generalisable. However, the longitudinal approach adopted 
and the extent of data collected and analysed has not been embraced in previous studies 
reviewed. A major strength of this study was that only emergency admission critically 
ill patients who were ETF were included and elective surgical patients or patients 
transferred to the ICU from a ward or another hospital were excluded. These criteria 
enabled clear identification of diarrhoea relationships in critically ill patients. 
 The single centre setting may be seen as both a strength and weakness. The 
limitation of the single centre is that study findings may not be generalised to the wider 
ICU community. Conversely, the strength of this approach is that bias between patient 
characteristics and local unit clinical protocols has not influenced the study findings. A 
notable limitation of this study was 1) no diarrhoea measurement tool was used by the 
ICU; therefore, clinicians based their subjective assessment of faecal stool output on 
professional opinion; and 2) the researcher retrospectively applied a faecal stool output 
measurement tool to the patient’s faecal output which was recorded in the patient’s 
medical record. Subjective assessment of faecal stool output has been associated with 
inaccurate stool quantification. The higher incidence of diarrhoea observed in this study 
may be in part, related to the subjective nature of stool assessment. The final limitation 
of this study is the study’s oversight to examine the relationships between aerobic 
intestinal microflora, enteral nutrition and diarrhoea in critically ill patients. 
 
RECOMMENDATIONS 
The results of this study reinforce that diarrhoea in ETF critically ill patients is 
caused by many factors. Recommendations for clinical practice and future research 
arising from this study include 1) re-examine ETF related diarrhoea risk factors in all 
subsets of critically ill patients; 2) develop and validate a faecal output measurement 
tool that is appropriate for use in critically ill patients; 3) implement a diarrhoea 
measurement tool to quantify faecal output; and 4) conduct prospective exploratory 
research that examines the relationships between aerobic intestinal microflora, enteral 
nutrition and diarrhoea in critically ill patients. 
 CONCLUSION 
This paper has presented findings related to diarrhoea risk factors and the 
prevalence of diarrhoea in a single centre ICU. The findings suggest that diarrhoea in 
ETF critically ill patients has many causes; however, the degree of involvement of these 
diarrhoea risk factors varies between critically ill patients. The differences in diarrhoea 
risk factors may in part be related to the inconsistent approaches to defining diarrhoea. 
Few studies have examined aerobic bacteria, enteral nutrition and diarrhoea 
relationships in critically ill patients. This paucity of knowledge requires future 
research. 
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